Valuation: Precision Therapeutics Inc

Market Cap 111M 95.28M 89.15M 81.6M 153M 10.64B 155M 1.05B 411M 5.35B 418M 409M 17.68B P/E 2024
-0.35x
P/E 2025 -0.53x
Enterprise Value 102M 87.46M 81.83M 74.91M 141M 9.77B 142M 967M 377M 4.91B 383M 375M 16.23B EV / Sales 2024
4.23x
EV / Sales 2025 121x
Free-Float
94.39%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 57 09/02/2026
Director of Finance/CFO - 16/04/2026
President - 01/04/2026
Director TitleAgeSince
Director/Board Member 66 19/02/2020
Chairman 78 09/02/2026
Director/Board Member 60 09/07/2020
Change 5-day change 1-year change 3-year change Capi.($)
-7.56%-8.33% - - 111M
+1.09%+5.26%+4.44%+26.03% 51.22B
-1.32%+2.49%+472.31%+598.96% 45.38B
+2.24%+8.63%+20.22%+92.46% 41.97B
+0.72%+9.35%+39.59%+20.73% 42.15B
-0.93%-4.80%+17.39%+46.60% 31.95B
+0.29%+3.14% - - 16.73B
+2.05%+7.90%+37.70%+153.77% 17.1B
+0.03%+3.41%+7.12%+35.49% 14.76B
+1.85%+6.07%+92.21%+47.85% 13.91B
Average -0.16%+3.19%+86.37%+127.74% 30.58B
Weighted average by Cap. +0.56%+3.13%+103.57%+149.27%

Financials

2024 2025
Net sales 1.62M 1.39M 1.3M 1.19M 2.24M 155M 2.27M 15.38M 6M 78.05M 6.1M 5.96M 258M 125K 107K 100K 91.92K 173K 11.99M 175K 1.19M 463K 6.02M 470K 460K 19.92M
Net income -12.66M -10.85M -10.15M -9.29M -17.44M -1.21B -17.67M -120M -46.77M -609M -47.55M -46.52M -2.01B -233M -200M -187M -171M -321M -22.3B -325M -2.21B -861M -11.2B -875M -856M -37.06B
Net Debt 1.4M 1.2M 1.12M 1.02M 1.92M 134M 1.95M 13.22M 5.16M 67.11M 5.24M 5.13M 222M -9.12M -7.82M -7.31M -6.69M -12.56M -873M -12.73M -86.41M -33.7M -439M -34.26M -33.52M -1.45B
Logo Precision Therapeutics Inc
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
Employees
-